Market Reports Center One Stop Market Reaserch Shop Epilepsy Drugs Market Share, Size, Global Insights, Emerging Trends, Growth Drivers and Future Outlook: Market Reports Center Summary Technavio Announces the Publication of its Research Report – Global Epilepsy Drugs Market 2016-2020 Technavio recognizes the following companies as the key players in the global epilepsy drugs market: Eisai, GSK, Pfizer, and UCB. Other Prominent Vendors in the market are: Acorda Therapeutics, Alexza Pharmaceuticals, Aprecia Pharmaceuticals, Aurobindo Pharma, Biscayne Pharmaceuticals, CURx Pharmaceuticals, Dainippon Sumitomo Pharma, D-Pharm, F. Hoffmann-La Roche, Grupo Ferrer Internacional, GW Pharmaceuticals, Insero Health, INSYS Therapeutics, Janssen Pharmaceuticals, Ligand Pharmaceuticals, H. Lundbeck, MarcoPolo Pharmaceuticals, Marinus Pharmaceuticals, Meda, Neurelis, Nobelpharma, Novartis, Orphelia Pharma, SAGE Therapeutics, SciFlour, Sedpr Pharmaceuticals, Shire, SK Biopharmaceuticals, Sun Pharmaceutical, Sunovion Pharmaceuticals (US), Supernus Pharmaceuticals, Takeda, Turing Pharmaceuticals, Upsher-Smith, Valeant Pharmaceuticals, and Zogenix. ” Browse Detail Report With TOC @ https://marketreportscenter.com/reports/319887/global-epilepsy-drugs-market-2016-2020 Commenting on the report, an analyst from Technavio’ s team said: “A trend which will boost market growth is the reformulation of marketed drugs. Drug delivery systems such as dispersible and filmcoated tablets increase the efficacy of medicines either by increasing the bioavailability of the drug or by expanding patient compliance. This reformulation results in products with improved safety and efficacy profiles and provides an opportunity for drug manufacturers to extend the term of their drug's patents, delaying the market entry of generics. For instance, UCB, Pfizer, and GSK developed film-coated tablets Market Reports Center One Stop Market Reaserch Shop of Keppra, Neurontin, and Trobalt, respectively. Film-coated tablets offer specific properties such as taste-masking, moisture and light protection, superior product appearance, and mechanical resistance.” According to the report, a key growth driver is the tentative approval of late-stage pipeline molecules. Though a number of branded and generic drugs are available in the market to treat epilepsy, they provide only symptomatic treatment. Hence, the need for effective medications still prevails in the market. This has increased investment in the R&D of new drugs for epilepsy by companies such as Marinus Pharmaceuticals, SAGE Therapeutics, H. Lundbeck, and CURx Pharmaceuticals. Drugs in the regulatory filing and Phase III stages are expected to enter the market during the forecast period. Further, the report states that one challenge that could hamper market growth is the social stigma associated with epilepsy. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. About the Epilepsy Drugs Market Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology. Etiology varies according to the age of a person. Some individuals genetically inherit the disease while the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or stroke can also cause the disorder. Technavio’ s analysts forecast the global epilepsy drugs market to grow at a CAGR of 4.45% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global epilepsy drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent epilepsy and related seizures. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Market Reports Center One Stop Market Reaserch Shop Technavio's report, Global Epilepsy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Eisai • GSK • Pfizer • UCB Other prominent vendors • AbbVie • Acorda Therapeutics • Alexza Pharmaceuticals • Aprecia Pharmaceuticals • Aurobindo Pharma • Biscayne Pharmaceuticals • CURx Pharmaceuticals • Dainippon Sumitomo Pharma • D-Pharm • F. Hoffmann-La Roche • Grupo Ferrer Internacional • GW Pharmaceuticals • Insero Health • INSYS Therapeutics • Janssen Pharmaceuticals • Ligand Pharmaceuticals • H. Lundbeck • MarcoPolo Pharmaceuticals • Marinus Pharmaceuticals • Meda • Neurelis • Nobelpharma • Novartis • Orphelia Pharma • SAGE Therapeutics • SciFlour • Sedor Pharmaceuticals • Shire • SK Biopharmaceuticals • Sun Pharmaceutical • Sunovion Pharmaceuticals (US) Market Reports Center One Stop Market Reaserch Shop • Supernus Pharmaceuticals • Takeda • Turing Pharmaceuticals • Upsher-Smith • Valeant Pharmaceutical • Zogenix Market driver • Tentative approval of late-stage pipeline molecules • For a full, detailed list, view our report Market challenge • Social stigma associated with epilepsy • For a full, detailed list, view our report Market trend • Reformulation of marketed drugs • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’ s time when you purchase this market report. Details are provided within the report. Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/319887 Table of Content PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights Market Reports Center One Stop Market Reaserch Shop • Epilepsy: An overview PART 05: Pipeline analysis PART 06: Key buying criteria for anti-epileptic drugs PART 07: Market landscape • Market overview • Five forces analysis PART 08: Market segmentation by generation of drugs • First-generation anti-epileptic drugs • Second-generation anti-epileptic drugs • Third-generation anti-epileptic drugs PART 09: Market segmentation by spectrum of activity • Narrow-spectrum anti-epileptic drugs • Broad-spectrum anti-epileptic drugs PART 10: Market segmentation by type of seizures To Get Discount On The Report @ https://marketreportscenter.com/request-discount/319887 About Us: Market Reports Centeris an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable. Market Reports Center currently has more than 1,20,000 plus titles and 30+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages, Banking & Finance, Media and Government, Public Sector Studies. Contact Information: Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected] https://marketreportscenter.com Market Reports Center One Stop Market Reaserch Shop
According to the report, a key growth driver is the tentative approval of late-stage pipeline molecules. Though a number of branded and generic drugs are available in the market to treat epilepsy, they provide only symptomatic treatment
© Copyright 2024 Paperzz
